SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-10/A - Registration Statement for Securities of certain Canadian Issuers.: [Amend]
SEC Accession No. 0001104659-20-087426
Filing Date
2020-07-28
Accepted
2020-07-28 17:17:32
Documents
7

Document Format Files

Seq Description Document Type Size
1 F-10/A tm2021235d3_f10a.htm F-10/A 375195
2 EXHIBIT 5.1 tm2021235d3_ex5-1.htm EX-5.1 4800
3 GRAPHIC logo.jpg GRAPHIC 10073
4 GRAPHIC image_001.jpg GRAPHIC 12262
5 GRAPHIC image_002.jpg GRAPHIC 6765
6 GRAPHIC image_003.jpg GRAPHIC 7619
7 GRAPHIC image_004.jpg GRAPHIC 14427
  Complete submission text file 0001104659-20-087426.txt   452075
Mailing Address 2 BLOOR ST W., 7TH FLOOR TORONTO A6 M4W 3E2
Business Address 2 BLOOR ST W., 7TH FLOOR TORONTO A6 M4W 3E2 416 648-5555
Medicenna Therapeutics Corp. (Filer) CIK: 0001807983 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 0331
Type: F-10/A | Act: 33 | File No.: 333-238905 | Film No.: 201054752
SIC: 2834 Pharmaceutical Preparations